'Combination of these two vaccines...may lead to greater efficiencies for the healthcare system and achieve high levels of protection against COVID-19 and influenza with a single regimen.'
FILE PHOTO: FILE PHOTO: Vials labelled"COVID-19 Coronavirus Vaccine" and sryinge are seen in front of displayed Novavax logo in this illustration -Vaccine developer Novavax Inc said on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine.
The trial, to be conducted in Australia, will enroll 640 healthy adults between the ages of 50 and 70 years and who have either been previously infected with the coronavirus or given an authorized COVID-19 vaccine at least eight weeks prior to the study. Participants will receive a combination of the company's COVID-19 vaccine candidate, NVX-CoV2373, and its Influenza shot NanoFlu along with an adjuvant or vaccine booster.
"Combination of these two vaccines...may lead to greater efficiencies for the healthcare system and achieve high levels of protection against COVID-19 and influenza with a single regimen," Gregory Glenn, President of Research and Development at Novavax, said in a statement. Novavax had said in May it expects seasonal influenza and COVID-19 combination vaccines to likely be critical in combating emerging COVID-19 variants. Its vaccine NanoFlu/NVX-CoV2373 had elicited robust responses to both influenza A and B and protected against the coronavirus in pre-clinical studies.Our goal is to create a safe and engaging place for users to connect over interests and passions.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Novavax begins early-stage trial for combined influenza/COVID-19 vaccineVaccine developer Novavax Inc said on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine.
Weiterlesen »
Covid-19: UK passes 7 million confirmed Covid casesThe milestone comes as another 41,000 daily cases are recorded, but the real total is likely to be higher.
Weiterlesen »
Peru to build plant to make Sputnik V COVID-19 vaccine - PresidentPeruvian President Pedro Castillo said on Monday that the government has reached an agreement with Russia to install a plant to produce the Sputnik V COVID-19 vaccine. Castillo did not provide further information on the timeline for the installation or production targets during a speech broadcast on national television, but added that the health minister would provide further information. Peru signed a contract to buy 20 million doses of Sputnik V in July.
Weiterlesen »
New Zealand 'very close' to deal for more COVID-19 vaccinesNew Zealand is 'very close' to procuring more coronavirus vaccines and a deal could be announced this week, COVID-19 Response Minister Chris Hipkins said on Tuesday, as the country looks to get on top of an outbreak of the Delta variant.
Weiterlesen »
China’s Exports Strengthen, Despite Covid-19 DisruptionsExports unexpectedly expanded at a faster clip in August, shrugging off the impact of a global resurgence of the coronavirus pandemic, port congestion and supply bottlenecks.
Weiterlesen »
4 datos que debe saber sobre la variante Mu del COVID-194 datos que debe saber sobre la variante Mu del COVID-19
Weiterlesen »